Growth Metrics

Vertex Pharmaceuticals (VRTX) Net Income - Minority (2016 - 2018)

Historic Net Income - Minority for Vertex Pharmaceuticals (VRTX) over the last 8 years, with Q3 2018 value amounting to -$28.4 million.

  • Vertex Pharmaceuticals' Net Income - Minority fell 13313.06% to -$28.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$28.4 million, marking a year-over-year decrease of 13313.06%. This contributed to the annual value of -$13.7 million for FY2017, which is 9244.15% up from last year.
  • Latest data reveals that Vertex Pharmaceuticals reported Net Income - Minority of -$28.4 million as of Q3 2018, which was down 13313.06% from -$28.7 million recorded in Q2 2018.
  • Over the past 5 years, Vertex Pharmaceuticals' Net Income - Minority peaked at -$12.2 million during Q3 2017, and registered a low of -$196.0 million during Q2 2017.
  • Over the past 5 years, Vertex Pharmaceuticals' median Net Income - Minority value was -$153.5 million (recorded in 2015), while the average stood at -$106.9 million.
  • Its Net Income - Minority has fluctuated over the past 5 years, first crashed by 65486.98% in 2016, then skyrocketed by 9348.64% in 2017.
  • Over the past 5 years, Vertex Pharmaceuticals' Net Income - Minority (Quarter) stood at -$21.2 million in 2014, then tumbled by 625.6% to -$153.7 million in 2015, then dropped by 18.19% to -$181.6 million in 2016, then skyrocketed by 92.44% to -$13.7 million in 2017, then plummeted by 106.64% to -$28.4 million in 2018.
  • Its Net Income - Minority was -$28.4 million in Q3 2018, compared to -$28.7 million in Q2 2018 and -$29.8 million in Q1 2018.